Re: [MOL] thalidamide for brain tumors [00021] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Re: [MOL] thalidamide for brain tumors



Dr Burzynski, Texas, has been doing "experimental Tretment" with his
Antineoplaston. I am pretty sure that with v. good results. The main
cancer tipe he likes to treat is brain tumor.
Pls call "Prospective Patients Dpt." 281/597-0111. E-mail:
jpaszkowia@juno.com
You can have good hope. Pls keep me informed.
Good luck
enen@juno.com
enen@aol.com
On Thu, 1 Jan 1998 17:51:21 -0500 "Dot Doelger" <doelger@dnet.net>
writes:
>looking for last ditch effort for brain tumor.  Large tumor 
>Gliobalstoma
>multiforme removed after Thanksgiving.  Grown back to almost the same 
>size
>as of Monday.  Hope for help from Thalidamide.  Where can I get it or 
>get
>in a study immediately.  Not much time left may be days.
>Laura.
>76102.3612@compuserve.com
>------------------------------------------------------------------------
>This is an automatically-generated notice.  If you'd like to be 
>removed
>from the mailing list, please visit the Medicine-On-Line Discussion 
>Forum
>at <http://www.meds.com/con_faq.html>, or send an email message to:
>majordomo@lists.meds.com
>with the subject line blank and the body of the message containing the 
>line:
>unsubscribe mol-cancer your-email-address
>where the phrase your-email-address is replaced with your actual email
>address.
>------------------------------------------------------------------------
>
------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------